The present study provides new insights into the mechanisms underlying renal damage in response to intravenous administration of radiocontrast into CKD patients and the potential nephroprotective effects of either carnitine or PDE-5 inhibitors against CIN in these patients. Here, PDE5A is linked to chronic kidney disease.